Showing results (2001-2010 of 2,033) with videos related to
Sort By:
Pageof 204
Pain|April 28, 2026
Towards a tool to discriminate between pain mechanistic descriptors: expert ranking of clinical features and allocation of weights using a forced choice paradigmMuath A Shraim, Michele Sterling, Kathleen A Sluka, et al.Cancer Immunology, Immunotherapy : CII|January 8, 2021
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinomaPedro Rocha, Ruth Salazar, Jiexin Zhang, et al.Brain Communications|March 10, 2023
Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a UK national cohortAndreas C Themistocleous, Georgios Baskozos, Iulia Blesneac, et al.Pain|October 21, 2024
Harmonizing neuropathic pain research: outcomes of the London consensus meeting on peripheral tissue studiesSara Villa, Eske K Aasvang, Nadine Attal, et al.The Lancet. Neurology|April 19, 2025
Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysisNadia Soliman, Xavier Moisset, Michael C Ferraro, et al.Pain|June 9, 2017
Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsJan Vollert, Christoph Maier, Nadine Attal, et al.Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.Respiratory Research|April 27, 2021
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohortWilliam Z Zhang, Katherine L Hoffman, Kristen T Schiffer, et al.Environmental Health Perspectives|December 6, 2008
Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-makingTracey J Woodruff, Lauren Zeise, Daniel A Axelrad, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 17, 2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcementM R Hutchinson, A L Northcutt, T Hiranita, et al.Pageof 204